| CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest E Sick, A Jeanne, C Schneider, S Dedieu, K Takeda, L Martiny British journal of pharmacology 167 (7), 1415-1430, 2012 | 200 | 2012 |
| LRP-1 promotes cancer cell invasion by supporting ERK and inhibiting JNK signaling pathways B Langlois, G Perrot, C Schneider, P Henriet, H Emonard, L Martiny, ... PloS one 5 (7), e11584, 2010 | 113 | 2010 |
| Original insights on thrombospondin-1-related antireceptor strategies in cancer A Jeanne, C Schneider, L Martiny, S Dedieu Frontiers in Pharmacology 6, 252, 2015 | 106 | 2015 |
| De novo ceramide synthesis is responsible for the anti-tumor properties of camptothecin and doxorubicin in follicular thyroid carcinoma G Rath, C Schneider, B Langlois, H Sartelet, H Morjani, HEL Btaouri, ... The international journal of biochemistry & cell biology 41 (5), 1165-1172, 2009 | 70 | 2009 |
| The C-terminal CD47/IAP-binding domain of thrombospondin-1 prevents camptothecin-and doxorubicin-induced apoptosis in human thyroid carcinoma cells GM Rath, C Schneider, S Dedieu, B Rothhut, M Soula-Rothhut, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1763 (10), 1125-1134, 2006 | 63 | 2006 |
| LRP-1–CD44, a new cell surface complex regulating tumor cell adhesion G Perrot, B Langlois, J Devy, A Jeanne, L Verzeaux, S Almagro, ... Molecular and cellular biology 32 (16), 3293-3307, 2012 | 56 | 2012 |
| Low-density lipoprotein receptor-related protein-1 mediates endocytic clearance of tissue inhibitor of metalloproteinases-1 and promotes its cytokine-like activities J Thevenard, L Verzeaux, J Devy, N Etique, A Jeanne, C Schneider, ... PloS one 9 (7), e103839, 2014 | 46 | 2014 |
| Contribution of the low-density lipoprotein receptor family to breast cancer progression O Campion, T Al Khalifa, B Langlois, J Thevenard-Devy, S Salesse, ... Frontiers in oncology 10, 882, 2020 | 32 | 2020 |
| Thrombospondin-1 C-terminal-derived peptide protects thyroid cells from ceramide-induced apoptosis through the adenylyl cyclase pathway GM Rath, C Schneider, S Dedieu, H Sartelet, H Morjani, L Martiny, ... The international journal of biochemistry & cell biology 38 (12), 2219-2228, 2006 | 29 | 2006 |
| LRP1 expression in colon cancer predicts clinical outcome C Boulagnon-Rombi, C Schneider, C Leandri, A Jeanne, V Grybek, ... Oncotarget 9 (10), 8849, 2018 | 28 | 2018 |
| Involvement of the 92-kDa gelatinase (matrix metalloproteinase-9) in the ceramide-mediated inhibition of human keratinocyte growth N Buisson-Legendre, P Bernard, H Bobichon, H Emonard, C Schneider, ... Biochemical and biophysical research communications 260 (3), 634-640, 1999 | 27 | 1999 |
| Influence of transforming growth factor β1 (TGF-β1) on the behaviour of porcine thyroid epithelial cells in primary culture through thrombospondin-1 synthesis D Claisse, I Martiny, B Chaqour, Y Wegrowski, E Petitfrere, C Schneider, ... Journal of Cell Science 112 (9), 1405-1416, 2000 | 26 | 2000 |
| Identification of TAX2 peptide as a new unpredicted anti-cancer agent A Jeanne, E Sick, J Devy, N Floquet, N Belloy, L Theret, ... Oncotarget 6 (20), 17981, 2015 | 24 | 2015 |
| Gefitinib induces EGFR and α5β1 integrin co-endocytosis in glioblastoma cells AF Blandin, E Cruz Da Silva, MC Mercier, O Glushonkov, P Didier, ... Cellular and Molecular Life Sciences 78, 2949-2962, 2021 | 23 | 2021 |
| A truncated form of CD9-partner 1 (CD9P-1), GS-168AT2, potently inhibits in vivo tumour-induced angiogenesis and tumour growth S Colin, W Guilmain, E Creoff, C Schneider, C Steverlynck, M Bongaerts, ... British journal of cancer 105 (7), 1002-1011, 2011 | 23 | 2011 |
| Matricellular TSP-1 as a target of interest for impeding melanoma spreading: towards a therapeutic use for TAX2 peptide A Jeanne, C Boulagnon-Rombi, J Devy, L Théret, C Fichel, N Bouland, ... Clinical & experimental metastasis 33, 637-649, 2016 | 21 | 2016 |
| TGFbeta1 effects on functional activity of porcine thyroid cells cultured in suspension N Delorme, C Remond, H Sartelet, E Petitfrere, C Clement, C Schneider, ... Journal of Endocrinology 173 (2), 345-355, 2002 | 21 | 2002 |
| Analysis of the effect of LRP-1 silencing on the invasive potential of cancer cells by nanomechanical probing and adhesion force measurements using atomic force microscopy A Le Cigne, L Chièze, A Beaussart, S El-Kirat-Chatel, YF Dufrêne, ... Nanoscale 8 (13), 7144-7154, 2016 | 19 | 2016 |
| Biobanking of fresh-frozen human adenocarcinomatous and normal colon tissues: Which parameters influence RNA quality? T Galissier, C Schneider, S Nasri, L Kanagaratnam, C Fichel, C Coquelet, ... PLoS One 11 (4), e0154326, 2016 | 17 | 2016 |
| Interleukin-1β-induced apoptosis through adenylyl cyclase and ERK1/2 inhibition in primary cultured thyroid cells H El Btaouri, G Rath, H Morjani, C Schneider, E Petitfrere, F Antonicelli, ... Biochemical and biophysical research communications 339 (2), 469-476, 2006 | 16 | 2006 |
